Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LACTOMASON is a South Korean biotechnology company specializing in the research, development, and large-scale production of probiotic raw materials and finished health supplements. The company utilizes its proprietary Multi-Coating Micro-encapsulation Technology (MCMT) to enhance the stability and survival rates of beneficial bacteria through the digestive tract. LACTOMASON operates as a comprehensive CDMO, offering services ranging from strain isolation and fermentation to OEM/ODM manufacturing for global markets. Their portfolio includes a wide array of patented probiotic strains targeting gut health, immunity, and women's health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LACTOMASON.